Discontinuation of rivastigmine in routi
β
Suzanne V. Frankfort; Bregje A. Appels; Anthonius de Boer; Linda R. Tulner; Jos.
π
Article
π
2005
π
John Wiley and Sons
π
English
β 59 KB
## Background: Rivastigmine is used for symptomatic treatment of mild-to-moderately severe alzheimer's dementia (ad). we investigated the frequency of and reasons for rivastigmine discontinuation in clinical practice and possible predictive factors for discontinuation within the first six months af